I agree that this site is using cookies. You can find further informations here.
X
Haferlach, C.
341  results:
Search for persons X
?
1

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic muta..:

Montoro, M.J. ; Palomo, L. ; Haferlach, C....
Leukemia Research.  128 (2023)  - p. 107187 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Topic: AS01-Diagnosis/AS01a-Cytomorphology: AUTOMATED DIGIT..:

Kanagal-Shamanna, R. ; Painter, D. ; Churpek, J....
Leukemia Research.  128 (2023)  - p. 107136 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene express..:

Sakuma, M. ; Meggendorfer, M. ; Kern, W....
Leukemia Research.  128 (2023)  - p. 107199 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P52 RISK STRATIFICATION COMBINING SKY92 GENE EXPRESSION PRO..:

Zhou, X. ; Hofmann, A. ; Vogt, C....
HemaSphere.  7 (2023)  S2 - p. 39-39 , 2023
Link: https://doi.org/10.1097/..
 
?
5

P411: SF3B1 MUTATIONS IN AML ARE STRONGLY ASSOCIATED WITH M..:

Huber, S. ; Hutter, S. ; Meggendorfer, M....
HemaSphere.  6 (2022)  - p. 311-312 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P404: PROGNOSTIC IMPACT OF CEBPA-MUTATIONAL SUBGROUPS IN AD..:

Georgi, J.-A. ; Stasik, S. ; Kramer, M....
HemaSphere.  6 (2022)  - p. 304-305 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P624: CHROMOTHRIPSIS IN PATIENTS WITH CLL AND COMPLEX KARYO..:

Ramos-Campoy, S. ; Puiggros, A. ; Kamaso, J....
HemaSphere.  6 (2022)  - p. 523-524 , 2022
Link: https://doi.org/10.1097/..
 
?
8

P735: THE ROLE OF SF3B1 MUTATIONS IN MYELODYSPLASTIC SYNDRO..:

Huber, S. ; Hutter, S. ; Meggendorfer, M....
HemaSphere.  6 (2022)  - p. 630-631 , 2022
Link: https://doi.org/10.1097/..
 
?
9

Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene express..:

Gurnari, C. ; Pagliuca, S. ; Guan, Y....
Leukemia Research.  108 (2021)  - p. 106680.1 , 2021
Link: https://doi.org/10.1016/..
 
?
10

European recommendations and quality assurance for cytogeno..:

Rack, K. A. ; van den Berg, E. ; Haferlach, C....
Leukemia.  34 (2020)  8 - p. 2262-2264 , 2020
Link: https://doi.org/10.1038/..
 
?
11

European recommendations and quality assurance for cytogeno..:

Rack, K. A. ; van den Berg, E. ; Haferlach, C....
Leukemia.  33 (2019)  8 - p. 1851-1867 , 2019
Link: https://doi.org/10.1038/..
 
?
12

MDS with deletions in the long arm of chromosome 11 are ass..:

Stengel, A ; Kern, W ; Meggendorfer, M..
Leukemia.  31 (2017)  9 - p. 1995-1997 , 2017
Link: https://doi.org/10.1038/..
 
?
13

Role of Screening for Molecular Mutations in Patients with ..:

Fasan, A. ; Haferlach, T. ; Haferlach, C..
Leukemia Research.  55 (2017)  - p. S107-S108 , 2017
Link: https://doi.org/10.1016/..
 
?
14

The molecular pathogenesis of the NUP98-HOXA9 fusion protei..:

Rio-Machin, A ; Gómez-López, G ; Muñoz, J...
Leukemia.  31 (2017)  9 - p. 2000-2005 , 2017
Link: https://doi.org/10.1038/..
 
?
15

Number of RUNX1 mutations, wild-type allele loss and additi..:

Stengel, A ; Kern, W ; Meggendorfer, M...
Leukemia.  32 (2017)  2 - p. 295-302 , 2017
Link: https://doi.org/10.1038/..
 
1-15